About Suraksha Diagnostic Limited
Data last updated: 18 December 2025
Suraksha Diagnostic Limited is a public limited company based in Kolkata, West Bengal, India. It specialises in other hospital and medical care activities, a part of the broader healthcare sector. Incorporated on 15 March 2005, the company has been in operation for over 21 years.
Registered with ROC Kolkata under CIN L85110WB2005PLC102265. Listed.
Capital: an authorised share capital of ₹14 Cr and a paid-up capital of ₹10.42 Cr. It is led by directors including Satish Kumar Verma and Siddhartha Roy.
Last AGM: 05 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156.
As per the financials filed for FY 2025, the company reported a revenue of ₹255.94 Cr, a growth of 15% compared to the previous year.
The company has a workforce of approximately 1,415 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Suraksha Diagnostics. As per MCA filings, the company has open charges of ₹11.32 Cr and satisfied charges of ₹274.15 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surakshanet.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Apps
-
Registered AddressPlot No Dg – 12/1 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156
-
IndustryHealthcare, Other Hospital And Medical Care Activities
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has one previous CIN (Corporate Identification Number): U85110WB2005PTC102265. The current CIN is L85110WB2005PLC102265, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L85110WB2005PLC102265 | Current |
| U85110WB2005PTC102265 | Previous |
Associated Brands with Suraksha Diagnostic Limited
Suraksha Diagnostic Limited operates one associated brand: Suraksha Diagnostics. These brands represent Suraksha Diagnostic Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Pathology, molecular diagnostics, and imaging services are provided. | surakshanet.com |
Competitors & Alternatives of Suraksha Diagnostic Limited
Brands and companies operating in the same space as Suraksha Diagnostic Limited include Thyrocare, Krsnaa Diagnostics, Vijaya Diagnostic Centre and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Diagnostic testing centers for pathology and health screenings are operated. | Mumbai, India, India | 1996 |
|
|
Chain of radiology & pathology laboratory centers | Pune, India, India | 2011 |
|
|
Diagnostic services are offered via a chain of centers. | Hyderabad, India, India | 1981 |
|
|
Provider molecular diagnostic solutions and services | Mumbai, India, India | 2013 |
|
|
Provider of medical diagnostic services including blood tests, urine tests, and specialized health check-ups | Pune, India, India | 2001 |
|
|
Chain of radiology & pathology laboratory centers | Pune, India, India | 2020 |
|
|
A chain of clinical laboratories is operated for diagnostic services. | Mumbai, India, India | 2007 |
|
|
Chain of diagnostic centers | Chennai, India, India | 2000 |
|
|
Medical diagnostic services are provided through a chain of centres. | Chennai, India, India | 2008 |
Business Activity of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | ********* |
Auditor Details of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is audited by MSKA & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2027-07-31) for the financial year 2026, as reported in its NSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| MSKA & ASSOCIATES LLP (ICAI peer reviewed, certificate valid till 2027-07-31) | FY 2026 | Declaration of unmodified opinion |
Board of Directors of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is currently managed by 9 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Satish Kumar Verma
Also directs:
Srd Agencies Llp, Reliance Electronic Industries (India) Llp, Asv Electronics Llp and 5 more
|
Director | 16 Jul 2024 | 1 Years 11 Months | Current |
|
Siddhartha Roy
Also directs:
Amgoorie India Ltd
|
Director | 03 Oct 2024 | 1 Years 9 Months | Current |
| Somnath Chatterjee | Managing Director | 15 Mar 2005 | 21 Years 3 Months | Current |
| Ishani Ray | Director | 16 Jul 2024 | 1 Years 11 Months | Current |
|
Ritu Mittal
Also directs:
Suraksha Speciality Llp, Fetomat Wellness Private Limited, Suraksha Radiology Private Limited and 5 more
|
Managing Director | 08 Nov 2006 | 19 Years 8 Months | Current |
| Kanakayya Sathyamurthy Ravindra | Cfo | 01 Mar 2025 | 1 Years 4 Months | Current |
Financials of Suraksha Diagnostic Limited FY 2026 filings available
Suraksha Diagnostic Limited reported revenue of ₹310.41 Cr (up 23.14% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹310.41 Cr | ₹252.09 Cr |
| Other Income | ₹3.16 Cr | ₹3.85 Cr |
| Total Income | ₹313.58 Cr | ₹255.94 Cr |
| Cost of Materials Consumed | ₹36.48 Cr | ₹29.52 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 |
| Employee Benefit Expense | ₹53.26 Cr | ₹42.89 Cr |
| Finance Costs | ₹12.55 Cr | ₹8.39 Cr |
| Depreciation & Amortisation | ₹41.45 Cr | ₹35.3 Cr |
| Other Expenses | ₹125.29 Cr | ₹98.44 Cr |
| Total Expenses | ₹269.02 Cr | ₹214.53 Cr |
| Profit Before Exceptional Items & Tax | ₹44.56 Cr | ₹41.41 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹44.56 Cr | ₹41.41 Cr |
| Total Tax Expense | ₹13.15 Cr | ₹10.43 Cr |
| Net Profit | ₹31.4 Cr | ₹30.98 Cr |
| attributable to Owners | ₹32.19 Cr | ₹31.82 Cr |
| attributable to NCI | -₹78.46 Lakh | -₹84.62 Lakh |
| Other Comprehensive Income | ₹56.94 Lakh | -₹20.39 Lakh |
| Total Comprehensive Income | ₹31.97 Cr | ₹30.77 Cr |
| EBITDA (computed) | ₹98.56 Cr | ₹85.09 Cr |
| Basic EPS | ₹6.18 | ₹5.97 |
| Diluted EPS | ₹6.18 | ₹5.97 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹448.12 Cr | ₹333.52 Cr |
| Non-current Assets | ₹385.54 Cr | ₹286.37 Cr |
| Current Assets | ₹62.58 Cr | ₹47.15 Cr |
| Property, Plant & Equipment | ₹193.58 Cr | ₹147.14 Cr |
| Inventories | ₹8.14 Cr | ₹8.05 Cr |
| Trade Receivables | ₹22.76 Cr | ₹13.81 Cr |
| Cash & Equivalents | ₹3.21 Cr | ₹2.25 Cr |
| Equity (Net Worth) | ₹243.48 Cr | ₹210.23 Cr |
| Equity Share Capital | ₹10.42 Cr | ₹10.42 Cr |
| Borrowings (Non-current) | ₹17.76 Lakh | ₹2.88 Cr |
| Borrowings (Current) | ₹1.56 Cr | ₹2.95 Cr |
| Total Debt (computed) | ₹1.73 Cr | ₹5.83 Cr |
| Current Liabilities | ₹59.65 Cr | ₹42.72 Cr |
| Total Liabilities | ₹204.64 Cr | ₹123.29 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹81.83 Cr | ₹63.36 Cr |
| Investing Cash Flow | -₹52.17 Cr | -₹39.58 Cr |
| Financing Cash Flow | -₹28.69 Cr | -₹24.05 Cr |
| Capital Expenditure | ₹67.34 Cr | ₹42.02 Cr |
| Free Cash Flow (computed) | ₹14.48 Cr | ₹21.34 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹96.73 Lakh | -₹27.32 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹81.41 Cr | ₹77.69 Cr | ₹78.73 Cr | ₹72.59 Cr | ₹65.09 Cr | ₹59.51 Cr | ₹66.75 Cr |
| Other Income | ₹78.54 Lakh | ₹62.16 Lakh | ₹85.14 Lakh | ₹90.57 Lakh | ₹81.68 Lakh | ₹59.91 Lakh | ₹1.31 Cr |
| Total Income | ₹82.2 Cr | ₹78.31 Cr | ₹79.58 Cr | ₹73.49 Cr | ₹65.91 Cr | ₹60.11 Cr | ₹68.07 Cr |
| Cost of Materials Consumed | ₹10.16 Cr | ₹8.67 Cr | ₹8.9 Cr | ₹8.75 Cr | ₹8.85 Cr | ₹6.1 Cr | ₹7.93 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹13.67 Cr | ₹13.42 Cr | ₹13.39 Cr | ₹12.77 Cr | ₹10.2 Cr | ₹11.29 Cr | ₹11.02 Cr |
| Finance Costs | ₹3.92 Cr | ₹3.16 Cr | ₹2.78 Cr | ₹2.7 Cr | ₹2.06 Cr | ₹1.98 Cr | ₹2.13 Cr |
| Depreciation & Amortisation | ₹11.26 Cr | ₹10.56 Cr | ₹10.14 Cr | ₹9.48 Cr | ₹8.73 Cr | ₹8.83 Cr | ₹8.75 Cr |
| Other Expenses | ₹33.21 Cr | ₹32.44 Cr | ₹32.32 Cr | ₹27.31 Cr | ₹26.86 Cr | ₹23.87 Cr | ₹24.61 Cr |
| Total Expenses | ₹72.22 Cr | ₹68.25 Cr | ₹67.53 Cr | ₹61.02 Cr | ₹56.7 Cr | ₹52.07 Cr | ₹54.43 Cr |
| Profit Before Exceptional Items & Tax | ₹9.98 Cr | ₹10.06 Cr | ₹12.05 Cr | ₹12.47 Cr | ₹9.21 Cr | ₹8.05 Cr | ₹13.63 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹9.98 Cr | ₹10.06 Cr | ₹12.05 Cr | ₹12.47 Cr | ₹9.21 Cr | ₹8.05 Cr | ₹13.63 Cr |
| Total Tax Expense | ₹3.82 Cr | ₹2.82 Cr | ₹3.22 Cr | ₹3.29 Cr | ₹2.04 Cr | ₹2.06 Cr | ₹3.48 Cr |
| Net Profit | ₹6.16 Cr | ₹7.24 Cr | ₹8.83 Cr | ₹9.18 Cr | ₹7.17 Cr | ₹5.98 Cr | ₹10.16 Cr |
| attributable to Owners | ₹6.28 Cr | ₹7.52 Cr | ₹8.99 Cr | ₹9.4 Cr | ₹7.39 Cr | - | ₹10.34 Cr |
| attributable to NCI | -₹12.12 Lakh | -₹28.24 Lakh | -₹15.87 Lakh | -₹22.23 Lakh | -₹21.78 Lakh | - | -₹18.73 Lakh |
| Other Comprehensive Income | ₹28.38 Lakh | ₹9.52 Lakh | -₹42,000 | ₹19.46 Lakh | -₹6.34 Lakh | ₹12.24 Lakh | ₹3.44 Lakh |
| Total Comprehensive Income | ₹6.44 Cr | ₹7.34 Cr | ₹8.82 Cr | ₹9.37 Cr | ₹7.11 Cr | ₹6.11 Cr | ₹10.19 Cr |
| EBITDA (computed) | ₹25.15 Cr | ₹23.78 Cr | ₹24.97 Cr | ₹24.66 Cr | ₹20 Cr | ₹18.86 Cr | ₹24.51 Cr |
| Basic EPS | ₹1.21 | ₹1.44 | ₹1.73 | ₹1.80 | ₹1.42 | ₹1.18 | ₹1.94 |
| Diluted EPS | ₹1.21 | ₹1.44 | ₹1.73 | ₹1.80 | ₹1.42 | ₹1.18 | ₹1.94 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Revenue from Operations | ₹300.68 Cr | ₹249.1 Cr |
| Other Income | ₹4.35 Cr | ₹4.38 Cr |
| Total Income | ₹305.03 Cr | ₹253.48 Cr |
| Cost of Materials Consumed | ₹36.1 Cr | ₹28.95 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 |
| Employee Benefit Expense | ₹51.67 Cr | ₹41.91 Cr |
| Finance Costs | ₹12.34 Cr | ₹8.39 Cr |
| Depreciation & Amortisation | ₹39.6 Cr | ₹34.73 Cr |
| Other Expenses | ₹118.1 Cr | ₹95.65 Cr |
| Total Expenses | ₹257.82 Cr | ₹209.62 Cr |
| Profit Before Exceptional Items & Tax | ₹47.22 Cr | ₹43.86 Cr |
| Exceptional Items | ₹0 | ₹0 |
| Profit Before Tax | ₹47.22 Cr | ₹43.86 Cr |
| Total Tax Expense | ₹13.15 Cr | ₹10.42 Cr |
| Net Profit | ₹34.06 Cr | ₹33.44 Cr |
| Other Comprehensive Income | ₹56.94 Lakh | -₹20.39 Lakh |
| Total Comprehensive Income | ₹34.63 Cr | ₹33.24 Cr |
| EBITDA (computed) | ₹99.16 Cr | ₹86.97 Cr |
| Basic EPS | ₹6.54 | ₹6.42 |
| Diluted EPS | ₹6.54 | ₹6.42 |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Total Assets | ₹450.14 Cr | ₹333.1 Cr |
| Non-current Assets | ₹386.67 Cr | ₹288.83 Cr |
| Current Assets | ₹63.47 Cr | ₹44.27 Cr |
| Property, Plant & Equipment | ₹168.53 Cr | ₹139.38 Cr |
| Inventories | ₹8.12 Cr | ₹8.02 Cr |
| Trade Receivables | ₹24.86 Cr | ₹15.06 Cr |
| Cash & Equivalents | ₹2.3 Cr | ₹1.48 Cr |
| Equity (Net Worth) | ₹249.8 Cr | ₹214.31 Cr |
| Equity Share Capital | ₹10.42 Cr | ₹10.42 Cr |
| Borrowings (Non-current) | ₹13.2 Lakh | ₹2.88 Cr |
| Borrowings (Current) | ₹1.53 Cr | ₹2.95 Cr |
| Total Debt (computed) | ₹1.66 Cr | ₹5.83 Cr |
| Current Liabilities | ₹57.36 Cr | ₹38.21 Cr |
| Total Liabilities | ₹200.34 Cr | ₹118.79 Cr |
| Metrics | FY 2026 | FY 2025 |
|---|---|---|
| Operating Cash Flow | ₹80.23 Cr | ₹62.8 Cr |
| Investing Cash Flow | -₹51.25 Cr | -₹39.28 Cr |
| Financing Cash Flow | -₹28.15 Cr | ₹24.15 Cr |
| Capital Expenditure | ₹50.12 Cr | ₹35.39 Cr |
| Free Cash Flow (computed) | ₹30.11 Cr | ₹27.41 Cr |
| Dividends Paid | ₹0 | ₹0 |
| Net Change in Cash | ₹82.91 Lakh | ₹47.66 Cr |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹78.56 Cr | ₹75.58 Cr | ₹76.26 Cr | ₹70.28 Cr | ₹64.15 Cr | ₹58.57 Cr | ₹65.95 Cr |
| Other Income | ₹1.3 Cr | ₹98.66 Lakh | ₹96.72 Lakh | ₹1.1 Cr | ₹94.21 Lakh | ₹97.45 Lakh | ₹1.26 Cr |
| Total Income | ₹79.86 Cr | ₹76.57 Cr | ₹77.23 Cr | ₹71.37 Cr | ₹65.09 Cr | ₹59.54 Cr | ₹67.2 Cr |
| Cost of Materials Consumed | ₹10.03 Cr | ₹8.58 Cr | ₹8.8 Cr | ₹8.69 Cr | ₹8.59 Cr | ₹5.99 Cr | ₹7.83 Cr |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹13.23 Cr | ₹13.03 Cr | ₹12.99 Cr | ₹12.41 Cr | ₹10 Cr | ₹11.01 Cr | ₹10.71 Cr |
| Finance Costs | ₹3.87 Cr | ₹3.1 Cr | ₹2.72 Cr | ₹2.66 Cr | ₹2.06 Cr | ₹2.03 Cr | ₹2.07 Cr |
| Depreciation & Amortisation | ₹10.69 Cr | ₹10.11 Cr | ₹9.65 Cr | ₹9.15 Cr | ₹8.66 Cr | ₹8.62 Cr | ₹8.58 Cr |
| Other Expenses | ₹31.49 Cr | ₹30.78 Cr | ₹30.5 Cr | ₹25.34 Cr | ₹25.74 Cr | ₹23.47 Cr | ₹23.84 Cr |
| Total Expenses | ₹69.3 Cr | ₹65.6 Cr | ₹64.66 Cr | ₹58.25 Cr | ₹55.05 Cr | ₹51.13 Cr | ₹53.02 Cr |
| Profit Before Exceptional Items & Tax | ₹10.56 Cr | ₹10.97 Cr | ₹12.57 Cr | ₹13.12 Cr | ₹10.04 Cr | ₹8.42 Cr | ₹14.18 Cr |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | ₹10.56 Cr | ₹10.97 Cr | ₹12.57 Cr | ₹13.12 Cr | ₹10.04 Cr | ₹8.42 Cr | ₹14.18 Cr |
| Total Tax Expense | ₹3.85 Cr | ₹2.83 Cr | ₹3.21 Cr | ₹3.27 Cr | ₹2.03 Cr | ₹2.06 Cr | ₹3.43 Cr |
| Net Profit | ₹6.71 Cr | ₹8.14 Cr | ₹9.36 Cr | ₹9.85 Cr | ₹8.01 Cr | ₹6.36 Cr | ₹10.75 Cr |
| Other Comprehensive Income | ₹28.38 Lakh | ₹9.52 Lakh | -₹42,000 | ₹19.46 Lakh | -₹6.34 Lakh | ₹12.24 Lakh | ₹3.44 Lakh |
| Total Comprehensive Income | ₹6.99 Cr | ₹8.24 Cr | ₹9.36 Cr | ₹10.04 Cr | ₹7.94 Cr | ₹6.48 Cr | ₹10.78 Cr |
| EBITDA (computed) | ₹25.11 Cr | ₹24.18 Cr | ₹24.94 Cr | ₹24.93 Cr | ₹20.76 Cr | ₹19.07 Cr | ₹24.83 Cr |
| Basic EPS | ₹1.29 | ₹1.56 | ₹1.80 | ₹1.89 | ₹1.54 | ₹1.22 | ₹2.02 |
| Diluted EPS | ₹1.29 | ₹1.56 | ₹1.80 | ₹1.89 | ₹1.54 | ₹1.22 | ₹2.02 |
Shareholding Pattern of Suraksha Diagnostic Limited
As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 49.10%, foreign institutional investors hold 13.46%, domestic institutional investors hold 23.14%, retail and other public shareholders hold 14.31% of Suraksha Diagnostic Limited. The company had 67,107 shareholders on record.
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | |
|---|---|---|---|---|---|---|
| Promoters | 49.10% | 49.00% | 48.98% | 48.88% | 48.78% | 48.78% |
| Public | 50.90% | 51.00% | 51.02% | 51.12% | 51.22% | 51.22% |
| Mar 2026 | Mar 2025 | |
|---|---|---|
| Promoters | 49.10% | 48.78% |
| Public | 50.90% | 51.22% |
| Promoter change (YoY, %pts) | +0.32 | - |
Board & Governance of Suraksha Diagnostic Limited
As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Suraksha Diagnostic Limited has 7 directors - 4 independent and 2 executive. The board is chaired by Dr. Somnath Chatterjee.
| Director | Position | On board since | Listed boards |
|---|---|---|---|
| Dr. Somnath Chatterjee | Executive Director · MD · Chairperson | 2005-03-15 | 1 |
| Ritu Mittal | Executive Director · CEO-MD | 2006-11-08 | 1 |
| Satish Kumar Verma | Non-Executive - Non Independent Director | 2024-07-16 | 3 |
| Pradip Kumar Dutta | Non-Executive - Independent Director | 2024-07-16 | 1 |
| Ishani Ray | Non-Executive - Independent Director | 2024-07-16 | 4 |
| Siddhartha Roy | Non-Executive - Independent Director | 2024-10-03 | 1 |
| Dharam Chand Dharewa | Non-Executive - Independent Director | 2024-10-03 | 2 |
| Committee | Members |
|---|---|
| Audit Committee | Ishani Ray (Chairperson), Dharam Chand Dharewa, Ritu Mittal |
| Nomination and remuneration committee | Ishani Ray (Chairperson), Pradip Kumar Dutta, Satish Kumar Verma, Siddhartha Roy |
| Stakeholders Relationship Committee | Siddhartha Roy (Chairperson), Dr. Somnath Chatterjee, Ritu Mittal, Pradip Kumar Dutta |
| Corporate Social Responsibility Committee | Dr. Somnath Chatterjee (Chairperson), Ritu Mittal, Dharam Chand Dharewa |
| Management and Finance Committee | Dr. Somnath Chatterjee (Chairperson), Ritu Mittal, Dharam Chand Dharewa |
Group Structure of Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has 1 subsidiary company. This group structure data is as of FY 2024. The corporate group structure reflects Suraksha Diagnostic Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Suraksha Radiology Private Limited | U86905WB2023PTC265197 | - |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Suraksha Diagnostic Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2025 | Others | ₹60 Lakh | Open |
| 15 May 2023 | Hdfc Bank Limited | ₹50 Lakh | Open |
| 28 Apr 2022 | Hdfc Bank Limited | ₹15 Lakh | Open |
| 26 Nov 2021 | Hdfc Bank Limited | ₹5.41 Cr | Open |
| 04 Oct 2021 | Hdfc Bank Limited | ₹2.65 Cr | Open |
Total charge records: 47 View all charges
Employees and EPFO Compliance at Suraksha Diagnostic Limited
Suraksha Diagnostic Limited has a workforce of 1,415 employees as of Mar 24, 2024.
Employee Count & EPFO Data of Suraksha Diagnostic Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Suraksha Diagnostic Limited
GSTIN & GST Filing Data of Suraksha Diagnostic Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Suraksha Diagnostic Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Suraksha Diagnostic Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Suraksha Diagnostic Limited
MSME Payment Delays by Suraksha Diagnostic Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Suraksha Diagnostic Limited
Subsidiaries & Group Companies of Suraksha Diagnostic Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Suraksha Diagnostic Limited with ownership details.
MCA Filings & Documents of Suraksha Diagnostic Limited
MCA Filings & Documents of Suraksha Diagnostic Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Suraksha Diagnostic Limited
Recent News on Suraksha Diagnostic Limited
Frequently Asked Questions about Suraksha Diagnostic Limited
Suraksha Diagnostic Limited is an active public limited company in the healthcare sector based in Kolkata, West Bengal, India. It was incorporated on 15 March 2005 (21+ years old) and is registered under CIN L85110WB2005PLC102265. The company has 1,415 employees.
Suraksha Diagnostic Limited reported revenue of ₹255.94 Cr for FY 2025 (up 15.00% YoY).
The current directors of Suraksha Diagnostic Limited are:
The primary industry of Suraksha Diagnostic Limited is healthcare. The company specifically operates in other hospital and medical care activities. The company is currently active in this sector.
Yes, Suraksha Diagnostic Limited is a listed company.
Suraksha Diagnostic Limited can be reached at the registered office: Plot No Dg – 121 Action Area 1D Premises No 02 – 0327 New Town Rajarhat, Kolkata, West Bengal, India – 700156, or through the website surakshanet.com.